News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy
Muhammad Umair Mushtaq/LinkedIn
Jan 23, 2025, 02:32

Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy

Muhammad Umair Mushtaq, Associate Professor of Medicine at the University of Kansas Medical Center, shared a post on LinkedIn:

“Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection. Journal of Clinical Apheresis. 2025; 40(1): e70004 (PMID: 39810305)”

Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection

Authors: Rajat Bansal, Anthony Wiedel, Riley Hastings, Fred Boutz, Haitham Abdelhakim, Nausheen Ahmed, Muhammad Umair Mushtaq, Joseph McGuirk, Sunil Abhyankar

Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy

Anthony Wiedel cancer Fred Boutz Haitham Abdelhakim Joseph McGuirk Muhammad Umair Mushtaq Nausheen Ahmed OncoDaily Oncology Rajat Bansal Riley Hastings Sunil Abhyankar
Special Coverage
Blog
Jan 23, 2025, 02:32
Tedros Adhanom Ghebreyesus: A productive discussion with President Samia Suluhu
Blog
Jan 23, 2025, 02:32
European School of Oncology - Attend the Fourth Online Course of the CCI4EU series on 28 February 2025
Blog
Jan 23, 2025, 02:32
Rob Winn: Eliminating the cancer burden and ensuring that the miracle medicine reaches every community
Blog
Jan 23, 2025, 02:32
Children's Cancer Institute - Cancer Australia consulted on the Draft National Framework for Genomics in Cancer Control
Blog
Jan 23, 2025, 02:32
Bruce Dunbar: Lung cancer is still the number 1 cancer killer
Blog
Jan 23, 2025, 02:32
Shaun Lintern: Thousands of NHS patients have died, gone blind or suffered serious injuries because of delays in their care
Blog
Jan 23, 2025, 02:32
Susan Galbraith: 5 key trends that have the potential to transform cancer care
Blog
Jan 23, 2025, 02:32
Christian Ntizimira: It is not the living who close the eyes of the dying, but the dying who open the eyes of the living
Blog
Jan 23, 2025, 02:32
Manoj Reddy: Honoring the legacy of Dr. Martin Luther King Jr.
Blog
Jan 23, 2025, 02:32
Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy
Blog
Jan 23, 2025, 02:32
The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer
Blog
Jan 23, 2025, 02:31
Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer